Literature DB >> 8370723

Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance.

A J DeCross1, B J Marshall, R W McCallum, S R Hoffman, L J Barrett, R L Guerrant.   

Abstract

Since the methods for metronidazole susceptibility testing of Helicobacter pylori have not been standardized or validated, we compared three methods that are used to test the metronidazole susceptibilities of 25 isolates of H. pylori. Specifically, we examined the methods of Steer's replicator agar dilution, tube broth microdilution, and modified Kirby-Bauer disk diffusion. The metronidazole disk zone sizes obtained by the disk diffusion method correlated well (r = 0.74) with the MICs obtained by the agar dilution method. Afterward, the disk diffusion method was used to characterize the metronidazole susceptibilities of 44 isolates of H. pylori. Dual therapy (bismuth and metronidazole) proved to be highly effective against metronidazole-susceptible strains (81.6% eradication rate) but fared poorly against resistant strains (16.7% eradication rate; P < 0.01). Using agar dilution testing, we validated the modified Kirby-Bauer disk diffusion method for metronidazole susceptibility testing of H. pylori and conclude that it is practical, accurate, and clinically applicable.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370723      PMCID: PMC265681          DOI: 10.1128/jcm.31.8.1971-1974.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Clarithromycin and omeprazole for Helicobacter pylori.

Authors:  R P Logan; P A Gummett; B T Hegarty; M M Walker; J H Baron; J J Misiewicz
Journal:  Lancet       Date:  1992-07-25       Impact factor: 79.321

Review 2.  Campylobacters and gastroduodenal inflammation.

Authors:  M J Blaser; W R Brown
Journal:  Adv Intern Med       Date:  1989

3.  Metronidazole resistance in Helicobacter pylori.

Authors:  Y Glupczynski; A Burette; E De Koster; J F Nyst; M Deltenre; S Cadranel; L Bourdeaux; D De Vos
Journal:  Lancet       Date:  1990-04-21       Impact factor: 79.321

4.  Carbon-14 urea breath test for the diagnosis of Campylobacter pylori associated gastritis.

Authors:  B J Marshall; I Surveyor
Journal:  J Nucl Med       Date:  1988-01       Impact factor: 10.057

5.  A 20-minute breath test for helicobacter pylori.

Authors:  B J Marshall; M W Plankey; S R Hoffman; C L Boyd; K R Dye; H F Frierson; R L Guerrant; R W McCallum
Journal:  Am J Gastroenterol       Date:  1991-04       Impact factor: 10.864

Review 6.  The clinical significance of Campylobacter pylori.

Authors:  C P Dooley; H Cohen
Journal:  Ann Intern Med       Date:  1988-01       Impact factor: 25.391

7.  Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial.

Authors:  D Y Graham; G M Lew; D G Evans; D J Evans; P D Klein
Journal:  Ann Intern Med       Date:  1991-08-15       Impact factor: 25.391

8.  Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance.

Authors:  G D Bell; K Powell; S M Burridge; A Pallecaros; P H Jones; P W Gant; G Harrison; J E Trowell
Journal:  Aliment Pharmacol Ther       Date:  1992-08       Impact factor: 8.171

9.  Susceptibility of clinical isolates of Campylobacter pylori to twenty-one antimicrobial agents.

Authors:  C A McNulty; J C Dent
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

10.  Cure of duodenal ulcer associated with eradication of Helicobacter pylori.

Authors:  E A Rauws; G N Tytgat
Journal:  Lancet       Date:  1990-05-26       Impact factor: 79.321

View more
  27 in total

1.  Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in Singapore.

Authors:  Jie-Song Hua; Ho Bow; Peng-Yuan Zheng; Yeoh Khay-Guan
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  In vitro activities of a new ketolide, ABT-773, alone and in combination with amoxicillin, metronidazole, or tetracycline against Helicobacter pylori.

Authors:  S L Pendland; J L Prause; M M Neuhauser; N Boyea; J M Hackleman; L H Danziger
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

3.  Antibiotic susceptibility of Helicobacter pylori clinical isolates: comparative evaluation of disk-diffusion and E-test methods.

Authors:  K K Mishra; S Srivastava; A Garg; A Ayyagari
Journal:  Curr Microbiol       Date:  2006-09-12       Impact factor: 2.188

4.  Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains.

Authors:  A A van Zwet; J C Thijs; B de Graaf
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

5.  Sensitivity testing for Helicobacter pylori should be more widely available.

Authors:  G Cammarota; A Tursi; A Papa; G Fedeli; G Gasbarrini
Journal:  BMJ       Date:  1996-10-26

6.  Helicobacter pylori antibiotic resistance in Iran.

Authors:  Marjan Mohammadi; Delaram Doroud; Nazanin Mohajerani; Sadegh Massarrat
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

7.  Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran.

Authors:  Shohreh Farshad; Abdolvahab Alborzi; Aziz Japoni; Reza Ranjbar; Kazem Hosseini Asl; Parisa Badiee; Maneli Amin Shahidi; Marziyeh Hosseini
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

8.  Assessment of metronidazole susceptibility in Helicobacter pylori: statistical validation and error rate analysis of breakpoints determined by the disk diffusion test.

Authors:  S Chaves; M Gadanho; R Tenreiro; J Cabrita
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

9.  Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in the Netherlands.

Authors:  E J van der Wouden; A A van Zwet; G D Vosmaer; J A Oom; A de Jong; J H Kleibeuker
Journal:  Emerg Infect Dis       Date:  1997 Jul-Sep       Impact factor: 6.883

10.  Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases.

Authors:  P E Coudron; C W Stratton
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.